23, 2024 — As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of ...
The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in ...
Jaime Marshall is now able to enjoy steak for the first time in her life after a life-saving liver transplant from her sister ...
When you hear about hepatitis A, you may think of tainted food and water, but this liver infection can also be spread from ...
In 2021, alcohol-related liver cirrhosis accounted for about a quarter of the 46·4 million disability-adjusted life-years (DALYs) lost from liver disease globally, making alcohol a leading cause of ...
AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...
Comprehensive Insights Provided into the Epidemiology Segments and Forecasts, the Future Growth Potential of Diagnosis Rate, Disease Progression, and Diagnostic GuidelinesDublin, Dec. 05, 2024 (GLOBE ...
There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report.
Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.
SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium, 6 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the ...
The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due ...
Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...